Notifications
Back

MEDIA

Press Release

Bixink, as a first Korean company, to initiate study for its digital therapeutics device “OC FREE” in the U.S. soon

회사뉴스
5 Aug 2021
Views 502


Bixink, as a first Korean company, to initiate study for its digital therapeutics device “OC FREE” in the U.S. soon

https://www.hankyung.com/it/article/202102052557i

0
LIMBIX, an invested company of BIXINK, launches SparkRx under the U.S FDA Emergency Use Authorization Bixink Therapeutics and Professional Dietetics enter into partnership for the MUCOSAMIN® range, onco-supportive care, whereby Bixink will hold the exclusive distribution rights in the Asian region
List

Copyright 2021 - BIXINK   │   Terms of Use

 Contact   │   Privacy

6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258, 

Republic of Korea

Copyright 2021 - BIXINK │ Terms of Use │ Contact  │  Privacy

6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea